Dr. Natalia Murinova, MD

Dr. Murinova practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Dr. Murinova's NPI, 1548259237, was assigned on October 17, 2005. Dr. Murinova graduated from Comenius University in 1991. Dr. Murinova holds Washington license MD00044235.

Dr. Murinova's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Dr. Murinova's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Dr. Murinova to 1 more hospital and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Murinova practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Murinova's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Murinova is board certified in addiction medicine by the American Board of Preventive Medicine. Dmand AI has Dr. Murinova's licenses on file in 5 states: Washington, California, Alaska, Hawaii and Michigan.

Dmand AI lists acute mini-stroke (TIA), hereditary polyneuropathy, lower back pain, migraine and chronic headache, mini-stroke (TIA) and stroke among the conditions Dr. Murinova treats.

CMS data shows 241 Medicare services from Dr. Murinova across 7 procedure codes in 2024, for 217 Medicare patients. Medicare paid $18,754 for them.

CMS counts 217 Medicare patients who saw Dr. Murinova in 2024. The largest group is 65 to 74, with 98 patients. 64% of them have high blood pressure, and 64% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Murinova's median patient age at 45, with 76% women.

In 2024, Dr. Murinova wrote 548 Medicare Part D claims for 70 patients. 79% of them were for generic drugs. CMS names the drug for 441 of them, across 13 drugs with 11 or more claims each, at $114,296 in total drug cost. In 2023, CMS named 323 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Murinova for performance year 2024, reported through an alternative payment model (APM). Dr. Murinova accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Murinova as offering telehealth.

Dmand AI links 16 papers to Dr. Murinova, published from 2012 to 2025. 2012 was the busiest year, with 2. The most frequent topics are Analgesics, Opioid, Migraine Disorders and Chronic Pain. Dr. Murinova has published most often in Headache. Dr. Murinova's most frequent co-authors are Daniel Lawrence Krashin, MD, Jane Carol Ballantyne, MD and Zubair Ahmed, MD.

Dmand AI links Dr. Murinova to 2 clinical trials. Conditions studied include Migraine with Aura, Migraine without Aura and Foramen Ovale, Patent. Swedish Medical Center sponsors the most, 2.

CMS Open Payments shows 4 general payments to Dr. Murinova from 3 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Impel Pharmaceuticals Inc. paid the most, $143. It also lists 1 research payment totaling $649 in 2016.

Dr. Murinova graduated from Comenius University in 1991. Dr. Murinova is a member of AAN.

Dr. Murinova is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.